SEC Form 4 · accession 0001179110-18-006935
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett K Haumann
Officer — SVP Clin Dev & Chief Med Ofc
Period of report
May 14, 2018
Accepted (ET)
May 16, 2018 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 14, 2018 | A | 33,750 | $0.00 | A | 175,953 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018.